siRNA delivery technologies for mammalian systems

Abstract Inhibition of gene expression using the RNA interference (RNAi) pathway is rapidly becoming the method of choice for studying gene function in mammalian cells. However, successful knockdown of the target gene requires efficient delivery of short interfering RNAs (siRNAs). Several technologies have been developed that enable effective delivery of siRNAs to both cells in culture and whole animals. These technologies will allow the use of RNAi to study gene function in mammalian model systems in which classical methods are often limited and costly.

[1]  E. Wagner,et al.  Tumor targeting with surface-shielded ligand--polycation DNA complexes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Stacy L DeRuiter,et al.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Wolff,et al.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. , 1999, Human gene therapy.

[4]  J. Hagstrom,et al.  Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery , 2003, Gene Therapy.

[5]  Michael T. McManus,et al.  Gene silencing using micro-RNA designed hairpins. , 2002, RNA.

[6]  Howard Y. Chang,et al.  Genomewide view of gene silencing by small interfering RNAs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Ulbrich,et al.  Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. , 1998, Biochimica et biophysica acta.

[9]  Leaf Huang,et al.  Potentiation of cationic liposome-mediated gene delivery by polycations. , 1996, Biochemistry.

[10]  H. Too,et al.  Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent. , 2003, Biomaterials.

[11]  J. Hagstrom,et al.  Layer-by-layer deposition of oppositely charged polyelectrolytes on the surface of condensed DNA particles. , 1999, Nucleic acids research.

[12]  R. Goomer,et al.  The transcriptional start site for a human U6 small nuclear RNA gene is dictated by a compound promoter element consisting of the PSE and the TATA box. , 1992, Nucleic acids research.

[13]  G Blume,et al.  Molecular mechanism of the lipid vesicle longevity in vivo. , 1993, Biochimica et biophysica acta.

[14]  D. Friend,et al.  Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. , 1996, Biochimica et biophysica acta.

[15]  P. Cullis,et al.  Nomenclature for synthetic gene delivery systems. , 1997, Human gene therapy.

[16]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[17]  S. Kochanek,et al.  High-capacity 'gutless' adenoviral vectors. , 2001, Current opinion in molecular therapeutics.

[18]  S. Fesik,et al.  Specificity of short interfering RNA determined through gene expression signatures , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  William C Hahn,et al.  Lentivirus-delivered stable gene silencing by RNAi in primary cells. , 2003, RNA.

[20]  R. Scheule,et al.  Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. , 2002, Human gene therapy.

[21]  I. Verma,et al.  Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Bernards,et al.  Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.

[23]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[24]  Joseph Zabner,et al.  Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*) , 1995, The Journal of Biological Chemistry.

[25]  J. Bromberg,et al.  Adaptive and innate immune responses to gene transfer vectors: role of cytokines and chemokines in vector function , 2003, Gene Therapy.

[26]  Michael T. McManus,et al.  Small Interfering RNA-Mediated Gene Silencing in T Lymphocytes1 , 2002, The Journal of Immunology.

[27]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[28]  J H Senior,et al.  Interaction of positively-charged liposomes with blood: implications for their application in vivo. , 1991, Biochimica et biophysica acta.

[29]  David L. Lewis,et al.  Efficient delivery of siRNA for inhibition of gene expression in postnatal mice , 2002, Nature Genetics.

[30]  G. Zuber,et al.  Towards synthetic viruses. , 2001, Advanced drug delivery reviews.

[31]  Gero Decher,et al.  Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites , 1997 .

[32]  D. Engelke,et al.  Effective expression of small interfering RNA in human cells , 2002, Nature Biotechnology.

[33]  D. McDonald,et al.  Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. , 1997, The American journal of physiology.

[34]  Anton P. McCaffrey,et al.  Inhibition of hepatitis B virus in mice by RNA interference , 2003, Nature Biotechnology.

[35]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[36]  Inder M Verma,et al.  A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  I. Zuhorn,et al.  On the Mechanism of Cationic Amphiphile-mediated Transfection. To Fuse or not to Fuse: Is that the Question? , 2002, The Journal of Membrane Biology.

[38]  Haibin Xia,et al.  siRNA-mediated gene silencing in vitro and in vivo , 2002, Nature Biotechnology.

[39]  P. Chaudhary,et al.  Use of Lentiviral Vectors for Delivery of Small Interfering RNA , 2003, Cancer biology & therapy.

[40]  W. Forrester,et al.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[42]  Douglas S. Conklin,et al.  Gene expression: RNA interference in adult mice , 2002, Nature.

[43]  Ali Ehsani,et al.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.

[44]  J. Legendre,et al.  Gene transfer mediated by cationic lipids: lack of a correlation between lipid mixing and transfection. , 1997, Biochimica et biophysica acta.

[45]  C. L. Johnson,et al.  Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. , 2000, Human gene therapy.

[46]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[47]  R. Medzhitov,et al.  Retroviral delivery of small interfering RNA into primary cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Taira,et al.  Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. , 2003, Nucleic acids research.

[49]  P. Williams,et al.  Surgical procedures for intravascular delivery of plasmid DNA to organs. , 2002, Methods in enzymology.

[50]  N. Déglon,et al.  Lentiviral-mediated RNA interference. , 2002, Human gene therapy.

[51]  D. Baltimore,et al.  Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Coll,et al.  Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes , 2002, The journal of gene medicine.

[53]  B. Li,et al.  Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.

[54]  Luis Carrasco.  Entry of animal viruses and macromolecules into cells , 1994, FEBS letters.

[55]  Judy Lieberman,et al.  RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.

[56]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[57]  Patrick J. Paddison,et al.  RNA interference: the new somatic cell genetics? , 2002, Cancer cell.

[58]  K. Taira,et al.  U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells , 2002, Nature Biotechnology.

[59]  Mark E. Davis,et al.  Development of a nonviral gene delivery vehicle for systemic application. , 2002, Bioconjugate chemistry.

[60]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[61]  T. Tuschl,et al.  Analysis of gene function in somatic mammalian cells using small interfering RNAs. , 2002, Methods.

[62]  M. Woodle.  Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation. , 1993, Chemistry and physics of lipids.

[63]  Michael T. McManus,et al.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference , 2003, Nature Genetics.

[64]  J. Hagstrom,et al.  Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation. , 1996, Biochimica et biophysica acta.

[65]  R. Bernards,et al.  Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53* 210 , 2003, The Journal of Biological Chemistry.

[66]  F. Szoka,et al.  Mechanism of oligonucleotide release from cationic liposomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Michael T. McManus,et al.  Gene silencing in mammals by small interfering RNAs , 2002, Nature Reviews Genetics.

[68]  Patrick J. Paddison,et al.  An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo , 2003, Nature Genetics.

[69]  J. Wolff,et al.  A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. , 1999, Journal of cell science.

[70]  G. Hannon.  RNA interference : RNA , 2002 .

[71]  S. Reske,et al.  Gene silencing by adenovirus‐delivered siRNA , 2003, FEBS letters.

[72]  C Russell Middaugh,et al.  Barriers to nonviral gene delivery. , 2003, Journal of pharmaceutical sciences.

[73]  J. C. Belmonte,et al.  MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb , 2003, Nature Cell Biology.

[74]  A. Fire,et al.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Rossi,et al.  Functional siRNA expression from transfected PCR products. , 2002, RNA.

[76]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[77]  Kenneth A Howard,et al.  Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.